OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intermediate endpoints as surrogates for outcomes in cancer immunotherapy: a systematic review and meta-analysis of phase 3 trials
Zhishan Zhang, Qunxiong Pan, Mingdong Lu, et al.
EClinicalMedicine (2023) Vol. 63, pp. 102156-102156
Open Access | Times Cited: 10
Zhishan Zhang, Qunxiong Pan, Mingdong Lu, et al.
EClinicalMedicine (2023) Vol. 63, pp. 102156-102156
Open Access | Times Cited: 10
Showing 10 citing articles:
Bifidobacterium modulation of tumor immunotherapy and its mechanism
Bo Pei, Shixuan Peng, Chuying Huang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 18
Bo Pei, Shixuan Peng, Chuying Huang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 18
Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward
Abhenil Mittal, Myung Sun Kim, S. Terence Dunn, et al.
EClinicalMedicine (2024), pp. 102824-102824
Open Access | Times Cited: 4
Abhenil Mittal, Myung Sun Kim, S. Terence Dunn, et al.
EClinicalMedicine (2024), pp. 102824-102824
Open Access | Times Cited: 4
Dual-energy CT iodine concentration as a biomarker for immunotherapy treatment response in metastatic melanoma and renal cell carcinoma patients
Natalie Wiley, Mladen Zečević, Vivian Ho, et al.
European Radiology (2025)
Closed Access
Natalie Wiley, Mladen Zečević, Vivian Ho, et al.
European Radiology (2025)
Closed Access
Optimal early endpoint for second-line or subsequent immune checkpoint inhibitors in previously treated advanced solid cancers: a systematic review
Jingqiu Li, Xiaoding Zhou, Lei Wu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Jingqiu Li, Xiaoding Zhou, Lei Wu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
A system review of neoadjuvant immune checkpoint blockade for breast cancer
Yanle Ye, Zhishan Zhang, Hong Zhao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yanle Ye, Zhishan Zhang, Hong Zhao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Operationalizing intermediate clinical endpoints: A pragmatic framework for prostate cancer management trials
Xingyu Xiong, Shiyu Zhang, Jiajia Du, et al.
Cancer Treatment Reviews (2025) Vol. 136, pp. 102935-102935
Closed Access
Xingyu Xiong, Shiyu Zhang, Jiajia Du, et al.
Cancer Treatment Reviews (2025) Vol. 136, pp. 102935-102935
Closed Access
Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Huimeng Yan, Jinyuan Huang, Yingying Li, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Huimeng Yan, Jinyuan Huang, Yingying Li, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Disease-free survival as a surrogate for overall survival in early-stage pancreatic cancer trials: a correlation meta-analysis
L. Leite, Luiz F Costa de Almeida, Luis Filipe Miranda Rebelo da Conceição, et al.
BMJ Oncology (2025) Vol. 4, Iss. 1, pp. e000766-e000766
Open Access
L. Leite, Luiz F Costa de Almeida, Luis Filipe Miranda Rebelo da Conceição, et al.
BMJ Oncology (2025) Vol. 4, Iss. 1, pp. e000766-e000766
Open Access
The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real‐world multicenter analysis
Shih‐Yu Huang, Po‐Jung Su, C.-Y. Lin, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 1
Shih‐Yu Huang, Po‐Jung Su, C.-Y. Lin, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 1
The association of ROS1 mutation with cancer immunity and its impact on the efficacy of pan-cancer immunotherapy
Yingying Li, Hong Zhao, Jinyuan Huang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Yingying Li, Hong Zhao, Jinyuan Huang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Sex Disparities Revealed by Single-Cell and Bulk Sequencing Data and Their Impacts on the Efficacy of Immunotherapy in Esophageal Cancer
Huimeng Yan, Jinyuan Huang, Yingying Li, et al.
(2023)
Closed Access
Huimeng Yan, Jinyuan Huang, Yingying Li, et al.
(2023)
Closed Access
